CEL-SCI Stock Forecast, Price & News

CEL-SCI (NYSEAMERICAN:CVM) Frequently Asked Questions

How has CEL-SCI's stock been impacted by COVID-19 (Coronavirus)?

CEL-SCI's stock was trading at $9.74 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CVM stock has decreased by 32.1% and is now trading at $6.61.
View which stocks have been most impacted by COVID-19.

When is CEL-SCI's next earnings date?

CEL-SCI is scheduled to release its next quarterly earnings announcement on Monday, February 14th 2022.
View our earnings forecast for CEL-SCI.

How were CEL-SCI's earnings last quarter?

CEL-SCI Co. (NYSEAMERICAN:CVM) posted its quarterly earnings results on Wednesday, December, 22nd. The company reported ($0.19) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.09.
View CEL-SCI's earnings history.

When did CEL-SCI's stock split? How did CEL-SCI's stock split work?

Shares of CEL-SCI reverse split on Thursday, June 15th 2017. The 1-25 reverse split was announced on Monday, June 12th 2017. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 14th 2017. An investor that had 100 shares of CEL-SCI stock prior to the reverse split would have 4 shares after the split.

Who are CEL-SCI's key executives?

CEL-SCI's management team includes the following people:

• Geert R. Kersten, CEO, Chief Financial Officer, Treasurer & Director
• Patricia B. Prichep, Secretary & Senior Vice President-Operations
• Eyal Talor, Chief Scientific Officer
• William Jones, Vice President-Quality Assurance
• Daniel H. Zimmerman, Senior VP-Research & Cellular Immunology

Who are some of CEL-SCI's key competitors?

Some companies that are related to CEL-SCI include Replimune Group (REPL), Coherus BioSciences (CHRS), Molecular Partners (MOLN), Vaxcyte (PCVX), Immunocore (IMCR), Sangamo Therapeutics (SGMO), Immunovant (IMVT), SOPHiA Genetics (SOPH), Ocugen (OCGN), MeiraGTx (MGTX), Rubius Therapeutics (RUBY), Century Therapeutics (IPSC), Agenus (AGEN), Immatics (IMTX) and Vaxart (VXRT).
View all of CVM's competitors.

What other stocks do shareholders of CEL-SCI own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CEL-SCI investors own include Dynavax Technologies (DVAX), Inovio Pharmaceuticals (INO), TG Therapeutics (TGTX), Savara (SVRA), Molecular Templates (MTEM), Gilead Sciences (GILD), Heat Biologics (HTBX), Idera Pharmaceuticals (IDRA), VBI Vaccines (VBIV) and CymaBay Therapeutics (CBAY).

What is CEL-SCI's stock symbol?

CEL-SCI trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVM."

Who are CEL-SCI's major shareholders?

CEL-SCI's stock is owned by a number of retail and institutional investors. Top institutional investors include Calton & Associates Inc. (0.05%). Company insiders that own CEL-SCI stock include Eyal Talor, Geert R Kersten, John Cipriano, Patricia B Prichep, Peter R Young and Robert Eugene Watson.
View institutional ownership trends for CEL-SCI.

Which major investors are selling CEL-SCI stock?

CVM stock was sold by a variety of institutional investors in the last quarter, including Calton & Associates Inc.. Company insiders that have sold CEL-SCI company stock in the last year include Eyal Talor, and John Cipriano.
View insider buying and selling activity for CEL-SCI or view top insider-selling stocks.

How do I buy shares of CEL-SCI?

Shares of CVM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CEL-SCI's stock price today?

One share of CVM stock can currently be purchased for approximately $6.61.

How much money does CEL-SCI make?

CEL-SCI has a market capitalization of $285.84 million and generates $560 thousand in revenue each year. The company earns $-36.36 million in net income (profit) each year or ($0.93) on an earnings per share basis.

How many employees does CEL-SCI have?

CEL-SCI employs 2,020 workers across the globe.

What is CEL-SCI's official website?

The official website for CEL-SCI is www.cel-sci.com.

Where are CEL-SCI's headquarters?

CEL-SCI is headquartered at 8229 Boone Blvd Ste 802, VIENNA, VA 22182-2634, United States.

How can I contact CEL-SCI?

CEL-SCI's mailing address is 8229 Boone Blvd Ste 802, VIENNA, VA 22182-2634, United States. The company can be reached via phone at (703) 506-9460, via email at [email protected], or via fax at 703-506-9471.